Related Experiment Videos
Rhabdomyosarcoma metastasizing as a malignant ectomesenchymoma
1Department of Pathology, Hospital for Sick Children, University of Toronto, Ontario, Canada.
Ultrastructural Pathology
|September 30, 1999
Summary
This case study details a rare malignant ectomesenchymoma in a child, featuring rhabdomyosarcoma and ganglioneuroma components. The metastasis suggests biphenotypic tumor cell expression, a novel finding in pediatric rhabdomyosarcoma.
Area of Science:
- Pediatric Oncology
- Tumor Biology
- Cancer Genetics
Background:
- Rhabdomyosarcoma is a prevalent pediatric malignancy.
- It can present as a component of mixed mesenchymal tumors, such as malignant ectomesenchymoma.
- Understanding rare tumor variants is crucial for effective treatment.
Observation:
- A 13-year-old boy with paratesticular embryonal rhabdomyosarcoma developed a retroperitoneal metastasis.
- Histology revealed a mixture of rhabdomyoblasts, ganglion cells, and a third cell type with combined features.
- Electron microscopy and immunohistochemistry confirmed the distinct cell populations and the biphenotypic nature of the metastatic cells.
Findings:
- The metastatic lesion exhibited characteristics of malignant ectomesenchymoma with both rhabdomyosarcoma and ganglioneuroma components.
- A novel third cell population demonstrated combined rhabdomyoblastic and ganglionic differentiation.
- Immunohistochemistry confirmed biphenotypic expression, with cells positive for vimentin, desmin, S-100, and NSE.
Implications:
- This case suggests biphenotypic tumor cell expression may underlie malignant ectomesenchymoma development.
- The findings expand the understanding of rhabdomyosarcoma heterogeneity.
- Further research is needed to clarify the role of prior therapies in this phenomenon.